Three healthcare innovations that could transform medicine Fast Company Nawigacja wpisu Dr. Messman contributes to special edition of AAMC journal – Today@Wayne Biogen and Stoke Therapeutics Present Data that Further Support the Disease-Modifying Potential of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome, at the 2025 American Epilepsy Society (AES) Annual Meeting – Biogen
